ZA200703680B - 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide dirivatives - Google Patents

1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide dirivatives

Info

Publication number: ZA200703680B
Authority: ZA; South Africa
Prior art keywords: triazolylaminoaryl; dirivatives; sulfonamide; heteroaryl; sulfonamide dirivatives
Prior art date: 2004-10-08

Application number

ZA200703680A

Other languages

English (en)

Inventor

Huang Shenlin

Peter J Connolly

Steven A Middleton

Steven K Wetter

Lin Ronghui

Emanuel Stuart

Robert H Gruninger

Original Assignee

Jansen Pharmacautica N V

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-08

Filing date

2007-05-07

Publication date

2008-10-29

2007-05-07 Application filed by Jansen Pharmacautica N V filed Critical Jansen Pharmacautica N V

2008-10-29 Publication of ZA200703680B publication Critical patent/ZA200703680B/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Oncology (AREA)
Physical Education & Sports Medicine (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Psychiatry (AREA)
Communicable Diseases (AREA)
Cardiology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Virology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)

ZA200703680A 2004-10-08 2007-05-07 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide dirivatives ZA200703680B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US61711904P	2004-10-08	2004-10-08

Publications (1)

Publication Number	Publication Date
ZA200703680B true ZA200703680B (en)	2008-10-29

Family

ID=36148673

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200703680A ZA200703680B (en)	2004-10-08	2007-05-07	1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide dirivatives

Country Status (14)

Country	Link
US (2)	US7888380B2 (zh)
EP (1)	EP1797049A4 (zh)
JP (1)	JP2008515925A (zh)
KR (1)	KR20070061907A (zh)
CN (1)	CN101084200A (zh)
AU (1)	AU2005295016A1 (zh)
BR (1)	BRPI0516569A (zh)
CA (1)	CA2583150A1 (zh)
EA (1)	EA200700818A1 (zh)
IL (1)	IL182314A0 (zh)
MX (1)	MX2007004155A (zh)
NO (1)	NO20072310L (zh)
WO (1)	WO2006042215A1 (zh)
ZA (1)	ZA200703680B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008515925A (ja) *	2004-10-08	2008-05-15	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	１，２，４−トリアゾリルアミノアリール（ヘテロアリール）スルホンアミド誘導体
WO2008075152A1 (en) *	2006-12-15	2008-06-26	Pfizer Products Inc.	1- [4- (sulfonyl) -phenyl] -5- (benzyl) -ih-i, 2, 4-triazol derivatives as inhibitors of carbonic anhydrase for treating glaucoma or ocular hypertension
FR2953518B1 (fr)	2009-12-03	2012-01-20	Sanofi Aventis	Procede de preparation d'un derive de combretastatine
WO2013169793A2 (en) *	2012-05-09	2013-11-14	Ipierian, Inc.	Methods and compositions for tdp-43 proteinopathies
KR20240011574A (ko)	2022-07-19	2024-01-26	김학규	하우스의 수로관 연결시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5382674A (en)	1988-12-19	1995-01-17	Dowelanco	Preparation of 5-amino-1,2,4-triazole-3-sulfonamides
CO5011105A1 (es) *	1997-12-22	2001-02-28	Novartis Ag	Compuestos organicos para tratar la obesidad y desordenes relacionados, composiciones farmaceuticas que los comprenden y procesos para su preparacion
GB9918180D0 (en)	1999-08-02	1999-10-06	Smithkline Beecham Plc	Novel compositions
IL153144A0 (en)	2000-06-16	2003-06-24	Bayer Cropscience Ag	Method for preparing substituted 5-amino-n-phenyl-1,2,4-triazole-3-sulfonamides
DE10038020A1 (de)	2000-06-16	2001-12-20	Bayer Ag	Verfahren zur Herstellung von substituierten 5-Amino-N-phenyl-1,2.4-triazol-3-sulfonamiden
US6720338B2 (en) *	2000-09-20	2004-04-13	Abbott Laboratories	N-acylsulfonamide apoptosis promoters
YU51803A (sh) *	2000-12-22	2006-05-25	Ortho Mc Neil Pharmaceutical Inc.	Supstituisani derivati triazol diamina kao inhibitori kinaza
AU2003222310B2 (en) *	2002-05-03	2009-04-09	Janssen Pharmaceutica N.V.	Polymeric microemulsions
ES2378987T3 (es) *	2002-08-06	2012-04-19	Toray Industries, Inc.	Remedio o agente preventivo para una enfermedad renal y procedimiento para diagnosticar una enfermedad renal
AR042052A1 (es)	2002-11-15	2005-06-08	Vertex Pharma	Diaminotriazoles utiles como inhibidores de proteinquinasas
BRPI0507634A (pt) *	2004-02-11	2007-07-03	Janssen Pharmaceutica Nv	processo para preparação de compostos triazóis substituìdos
JP2008515925A (ja) *	2004-10-08	2008-05-15	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	１，２，４−トリアゾリルアミノアリール（ヘテロアリール）スルホンアミド誘導体

2005
- 2005-10-06 JP JP2007535886A patent/JP2008515925A/ja not_active Withdrawn
- 2005-10-06 US US11/245,314 patent/US7888380B2/en not_active Expired - Fee Related
- 2005-10-06 EA EA200700818A patent/EA200700818A1/ru unknown
- 2005-10-06 BR BRPI0516569-5A patent/BRPI0516569A/pt not_active Application Discontinuation
- 2005-10-06 AU AU2005295016A patent/AU2005295016A1/en not_active Abandoned
- 2005-10-06 MX MX2007004155A patent/MX2007004155A/es unknown
- 2005-10-06 CA CA002583150A patent/CA2583150A1/en not_active Abandoned
- 2005-10-06 EP EP05809950A patent/EP1797049A4/en not_active Withdrawn
- 2005-10-06 CN CNA2005800415390A patent/CN101084200A/zh active Pending
- 2005-10-06 KR KR1020077009701A patent/KR20070061907A/ko not_active Application Discontinuation
- 2005-10-06 WO PCT/US2005/036396 patent/WO2006042215A1/en active Application Filing
2007
- 2007-03-29 IL IL182314A patent/IL182314A0/en unknown
- 2007-05-04 NO NO20072310A patent/NO20072310L/no not_active Application Discontinuation
- 2007-05-07 ZA ZA200703680A patent/ZA200703680B/xx unknown
2010
- 2010-09-29 US US12/893,925 patent/US8299082B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1797049A4 (en)	2009-06-17
CA2583150A1 (en)	2006-04-20
US20060173020A1 (en)	2006-08-03
EA200700818A1 (ru)	2007-08-31
US20110077249A1 (en)	2011-03-31
AU2005295016A1 (en)	2006-04-20
IL182314A0 (en)	2007-07-24
MX2007004155A (es)	2007-09-11
CN101084200A (zh)	2007-12-05
JP2008515925A (ja)	2008-05-15
WO2006042215A1 (en)	2006-04-20
KR20070061907A (ko)	2007-06-14
BRPI0516569A (pt)	2008-09-16
EP1797049A1 (en)	2007-06-20
US7888380B2 (en)	2011-02-15
US8299082B2 (en)	2012-10-30
NO20072310L (no)	2007-06-14

Publication	Publication Date	Title
EP1663113A4 (en)	2007-06-13	SUBSTITUTED SULFONAMIDES
IL241732B (en)	2019-10-31	2-di-tert-butyloxycarbonylamino-6-bromo-9-(2-trimethylsilylethoxy)methyl-h9-purine
IL183706A0 (en)	2007-09-20	2,4(4,6) pyrimidine derivatives
ZA200606974B (en)	2008-04-30	Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
EG25273A (en)	2011-12-04	Substituted dihydroquinazolines.
AP2204A (en)	2011-02-07	4-phenylamino-quinazolin-6-yl-amides.
ZA200702452B (en)	2009-05-27	Sulfonamide compounds
ZA200606315B (en)	2008-02-27	Novel amido-substituted hydroxy-6-phenylphenanthridines
DE602004006169D1 (de)	2007-06-06	Substituierte 8'-pyri(mi)dinyl-dihydrospiro-äcycloalkylaminü-pyrimidoä1,2aüpyrimidin-6-onderivate
EP1830858A4 (en)	2010-06-23	3,6-BICYCLOLIDE
ZA200506744B (en)	2006-06-28	PyrazoloÄ1,5-AÜpyrimidine derivatives
ZA200704636B (en)	2008-09-25	2-alkyl-cycloalk(en)yl-carboxamides
AP2006003791A0 (en)	2006-10-31	1-Heterocyclyl-1,5-dihydro-pyridoÄ3,2-BÜindol-2-ones
HK1069009A1 (en)	2005-05-06	Electricals switch.
ZA200703680B (en)	2008-10-29	1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide dirivatives
EP1654232A4 (en)	2008-11-12	N- (BIARYLMETHYL) AMINOCYCLOPROPANECARBOXAMIDES WITH SULFONYL SUBSTITUTION
IL182538A0 (en)	2007-09-20	1,5-diheterocycle-1h-triazole derivative
EP1723145A4 (en)	2009-12-02	SUBSTITUTED 5,12-DIAZENZOANTHRACENANALOGA
GB0425572D0 (en)	2004-12-22	1,7-Naphthyridines
GB0316128D0 (en)	2003-08-13	Novel sulfonamide compounds
AU2003291303A8 (en)	2004-06-03	Sulfonamides
AU2003291262A8 (en)	2004-06-03	Sulfonamides
AU2003295408A8 (en)	2004-06-03	Sulfonamides
EP1711189A4 (en)	2009-12-23	AZALIDE DERIVATIVES 8A 6,11-3C-BICYCLIC
IL186226A0 (en)	2008-01-20	(3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines